KERX
Keryx Biopharmaceuticals Inc
KERX
KERX
Delisted
KERX was delisted on the 12th of December, 2018.
125 hedge funds and large institutions have $313M invested in Keryx Biopharmaceuticals Inc in 2018 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
125
Holders Change
-4
Holders Change %
-3.1%
% of All Funds
2.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
37
Reduced
36
Closed
17
Calls
$2.65M
Puts
$4.58M
Net Calls
-$1.93M
Net Calls Change
+$92K
Top Buyers
| 1 |
Millennium Management
New York
|
+$3.85M |
| 2 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
+$689K |
| 3 |
Goldman Sachs
New York
|
+$632K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$529K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$404K |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$2.75M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.46M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.43M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$823K |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$749K |
